26 Nov 2018 --- Scot Bio, a Scottish-based biotech business offering spirulina extract, has successfully closed a second, oversubscribed funding round with investment syndicate Kelvin Capital, Investing Women, Oghma Partners and private investors in the UK and US. With over £2 million (US$2.56 million) in new private funding promised, this makes it one of the largest private investment rounds in Scotland this year. The news is being hailed as “a vote of confidence in the ambitious prospects of the company.”